Brain Gene Expression Signatures From Cerebrospinal Fluid Exosome RNA Profiling by Bershad, E. et al.
BRAIN GENE EXPRESSION SIGNATURES FROM CEREBROSPINAL FLUID 
EXOSOME RNA PROFILING  
 
S. B. Zanello1, B. Stevens2, E. Calvillo2, R. Tang3, B. Gutierrez Flores3, L. Hu4, J. Skog4 and E. Bershad2 
 
1Universities Space Research Association, Houston, TX (email: susana.b.zanello@nasa.gov); 2Baylor College of 
Medicine, Houston, TX, 3University of Houston College of Optometry, Houston, TX and 4Exosome Diagnostics, 
Cambridge, MA. 
 
While the Visual Impairment and Intracranial Pressure (VIIP) syndrome observations have focused on 
ocular symptoms, spaceflight has been also associated with a number of other performance and 
neurologic signs, such as headaches, cognitive changes, vertigo, nausea, sleep/circadian disruption and  
mood alterations, which, albeit likely multifactorial, can also result from elevation of  intracranial 
pressure (ICP).  We therefore hypothesize that these various symptoms are caused by disturbances in the 
neurophysiology of the brain structures and are correlated with molecular markers in the cerebrospinal 
fluid (CSF) as indicators of neurophysiological changes.  
  Exosomes are 30-200 nm microvesicles shed into all biofluids, including blood, urine, and CSF, 
carrying a highly rich source of intact protein and RNA cargo. Exosomes have been identified in human 
CSF, and their proteome and RNA pool is a potential new reservoir for biomarker discovery in 
neurological disorders.   
  The purpose of this study is to investigate changes in brain gene expression via exosome analysis in 
patients suffering from ICP elevation of varied severity (idiopathic intracranial hypertension -IIH), a 
condition which shares some of the neuroophthalmological features of VIIP, as a first step toward 
obtaining evidence suggesting that cognitive function and ICP levels can be correlated with biomarkers in 
the CSF. 
  Our preliminary work, reported last year, validated the exosomal technology applicable to CSF analysis 
and demonstrated that it was possible to obtain gene expression evidence of inflammation processes in 
traumatic brain injury patients. We are now recruiting patients with suspected IIH requiring lumbar 
puncture at Baylor College of Medicine. Both CSF (5 ml) and human plasma (10 ml) are being collected 
in order to compare the pattern of differentially expressed genes observed in CSF and in blood. Since 
blood is much more accessible than CSF, we would like to determine whether plasma biomarkers for  
elevated ICP can be identified.  This may eventually lead to a blood test to diagnose intracranial 
hypertension. 
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